microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma.
about
MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic SclerosisStriae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment.17β-estradiol ameliorates age-associated loss of fibroblast function by attenuating IFN-γ/STAT1-dependent miR-7 upregulation.Circulating microRNAs serve as novel biological markers for intracranial aneurysms.Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.Pathogenesis of Systemic Sclerosis.Novel insights into a reputably irreversible process: combined mRNA and miRNA profiling of tissue from vesicourethral anastomotic stenosis after radical prostatectomy.Targeting miR-155 to Treat Experimental SclerodermaProtective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts.miR-7a/b attenuates post-myocardial infarction remodeling and protects H9c2 cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and PARP-1.The role of microRNAs in skin fibrosis.Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.Emerging role of epigenetics in systemic sclerosis pathogenesis.Facts and promises on lung biomarkers in interstitial lung diseases.microRNA deregulation in keloids: an opportunity for clinical intervention?MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.Unfolding the pathogenesis of scleroderma through genomics and epigenomics.From genetics to epigenetics: new insights into keloid scarring.The molecular pathogenesis of morphoea: from genetics to future treatment targets.Genome-Wide Scan for Methylation Profiles in Keloids.Expression of Let-7 family microRNAs in skin correlates negatively with severity of pulmonary hypertension in patients with systemic scleroderma.Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders.
P2860
Q26781257-52CC50D8-BF1F-4724-B43A-5DF734AE5AD4Q34377612-59EA94CB-9A5C-4A1F-992B-BA6337C44CCCQ34516423-E8C7F3A6-AFAC-4ACA-8094-B0692BCFCAFDQ35070658-EB16FCD0-BC79-4FE6-8626-369DE13035D3Q35553540-C2EE7D58-B299-4257-BC02-6670D3E8B540Q35693212-0694D326-C0D6-40B8-BB2E-3D9C217550EDQ36410973-84DDE677-CE37-4157-BDD6-3A6D9B9D154CQ36524910-35876256-DFDF-49F9-9C5B-5368C89D616CQ36965488-F19189A6-D079-4BB9-AF2E-D1CC7BBB98EDQ37072777-AB38BC14-14EB-4230-8425-3541E0554601Q37691772-A670C9EE-6699-4E40-B1CD-3CBA6CE7A012Q38205150-E7AC631E-FCCC-4CC4-ABE1-357611F2F6E7Q38230244-D3EB904A-C6CF-403D-9397-480841BCD156Q38543042-B7BDFA7B-B882-4BE7-90E9-4AD296F112C3Q38612431-012E6287-0A75-49A4-823D-4B748A63B7F5Q38654746-E19F6C61-5CFD-4819-BA12-4512A55F4FE3Q38681645-ABDB0B37-B7C5-4989-AAF1-CA7CAEAA98E8Q38774686-83579561-02AF-478D-90EF-BA27104FCDEAQ38828584-84C82B53-4BFA-4399-AD18-FCF05B8F5AFAQ40835446-6B712D8D-97DB-4656-9FF2-FABE3286F44DQ40963722-BB2E8AF7-6081-4699-A9DC-4D63DF6DD81AQ41936990-2D22C134-FF9F-441D-B414-986E7478CACC
P2860
microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@en
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@nl
type
label
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@en
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@nl
prefLabel
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@en
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@nl
P2093
P2860
P1476
microRNA-7 down-regulation med ...... sion in localized scleroderma.
@en
P2093
Hironobu Ihn
Ikko Kajihara
Katsunari Makino
Keitaro Yamane
Masatoshi Jinnin
Mitsuhiko Etoh
Noritoshi Honda
Satoshi Fukushima
Takamitsu Makino
P2860
P2888
P356
10.1007/S00403-012-1287-4
P577
2012-09-11T00:00:00Z